Skip to content

Use of Platelet Rich Fibrin Membrane (PRF) in Type 1 Tympanoplasty

Use of Platelet Rich Fibrin Membrane (PRF) reinforcement in Type 1 Tympanoplasty - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/05/066644
Enrollment
60
Registered
2024-05-01
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H720- Central perforation of tympanic membrane

Interventions

Intervention1: Use of Platelet Rich Fibrin membrane: Apart from using graft for type 1 tympanoplasty
additional PRF membrane will be used for 30 patients,over the period of 6 months Control Intervention1: Only Graft material (temporalis facia or perichondrium): No addition Of PRF on Graft in Type 1 T

Sponsors

Dharmsinh Desai University
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with age of 18 to 50years. Having tubotympanic type of CSOM with central perforation Having dry ear for 6 weeks Voluntarily agree to participate with consent.

Exclusion criteria

Exclusion criteria: Patients having complicated CSOM Patients with ossicular chain erosion Patients with cholesteatoma Not fit for surgery/Not willing for surgery Patient having SNHL or Mixed Hearing Loss Revision surgery

Design outcomes

Primary

MeasureTime frame
1.Success rate of graft uptake in Group with PRF(%) 2.Success rate of graft uptake in Group without PRF(%) Timepoint: Preoperative and Post op 3 months assessment

Secondary

MeasureTime frame
Hearing improvement in either group Pre operative and Post operative (3 months post op) audiogram will be compared to see AB gap closure.(mean of AB gap closure) Timepoint: Preoperative and Post op 3 months assessment

Countries

India

Contacts

Public ContactDrBhagyesh LDarji

Dr.N.D.Desai Faculty of Medical Sci. and research,Nadiad

bhagyesh.darji@gmail.com9953897332

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 27, 2026